Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The buy page supports commercial ordering intent, while the live product page remains the final source for checkout and current availability
Retatrutide (LY3437943) is a once-weekly injection that activates three different hormone receptors at the same time: GLP-1 (Glucagon-Like Peptide-1) receptor - controls blood sugar and appetite GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor - enhances insulin release and metabolism Glucagon receptor - increases energy expenditure and fat burning Think of it like this: Semaglutide (Ozempic) = Single agonist (GLP-1 only) Tirzepatide (Mounjaro) = Dual agonist (GLP-1 + GIP) Retatrutide = Triple agonist (GLP-1 + GIP + Glucagon) Each added receptor appears to amplify the benefits
On a 15kg weight loss, that is the difference between losing 5.4kg of lean mass versus 3.3kg
Aaron Erez explains: "Medication cant outpace an unhealthy lifestyle in the long run
Not all semaglutide medications are the same when it comes to breastfeeding safety
E-112-2007-0), has been developed in the laboratories of Drs
